Success and Failure at 24 Months of HAART in a Resource-poor Setting: Observational Cohort of 416 HIV-Treated Patients

Main objective 
• Retrospective cohort analysis of patients who started ARV 24 + 2 months ago and followed without viral load monitoring 
Secondary objectives 
• Description of success/failure clinico-immunological criteria at 24 months and at 6, 12 and 18 months 
• Identification of the reasons for virological failure at 24 months 
• Description of resistance mutations to ARV observed at 24 months 
• Analysis of the observance of the patients still on ARV at 24 months 
• Evaluation of ARV side-effects during the 24 months of treatment 
• Pharmacological analysis of ARV at 24 months